Conference abstract · 22 Nov 2021
Conference abstractPublished 17 Mar 2021
Modified PAS analogues making PAS great again
University of Minnesota, USA Hackensack Meridian Health, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tuberculosis (TB) is one of the deadliest infectious disease resulting in nearly 1.5 million deaths annually and infecting nearly one-quarter of the population. Para-aminosalicylic acid (PAS), an important second-line agent for treating drug-resistant mycobacteria, has low bioavailability and rapid clearance that necessitate high daily doses of up to 12 grams/day, which in turn causes severe gastrointestinal disturbances by disruption of gut microbiota and host epithelial cells. In this project we aim to improve the bioavailability of PAS, while retaining its anti-mycobacterial activity. We have developed a series of prodrugs that substantially increase the oral bioavailability, which prevents intestinal accumulation as well as undesirable bioactivation by the gut microbiome to non-natural folate species that exhibit cytotoxicity. The conceptually simple prodrug approach does not address the intrinsic rapid clearance of PAS by N-acetyltransferase (NAT); thus, we have also designed analogues of the PAS scaffold to lower clearance of PAS enzymes by sterically blocking N-acetylation and electronic deactivation of the para-amino group. Combination of these dual approaches together may provide a next-generation PAS drug with substantially higher oral exposure to prevent adverse reactions and development of resistance.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 28 Dec 2022
Yes We Can Make America Great Again: A Shift from Traditional Campaigning Methods to Public Relations Techniques
Short communication · 2018
Great Initiatives for a Great Cause: Policy Making In United Kingdom to Limit Smoking
Commentary · 2017
Pollution Threatens Human Fertility: It is Time to Make Our Gametes Great Again
Short communication · 20 Sep 2015
Using Native and Modified Starch in Processed Cheese Analogue Manufacture to Reduce Cost
More from this journal
The newest in Pulmonary & Respiratory Medicine.
Article · 9 Feb 2026
Magnitude and Associated Factors of Respiratory Distress Syndrome among Preterm Neonate Admitted to Addis Ababa Public Hospital, Ethiopia 2023/24
Commentary · 29 Dec 2025
Evolving IPF: Personalized Therapies, Future Directions
Brief report · 29 Dec 2025
PH/PAH: Advancements, Guidelines, Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPulmonary & Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Michael Howe”
- BylineArticles whose byline prints “Anthony Baughn”
- BylineArticles whose byline prints “Veronique Dartois”
- BylineArticles whose byline prints “Matthew Zimmerman”

